High-Dose Folic Acid and Autism: A Possible Link Theory – Mohammed Dlshad Noraldeen

The Relationship Between High-Dose Folic Acid and Autism Spectrum Disorder (A Theory)

1. Introduction

In recent years, there has been a growing trend among individuals planning to conceive to take supplements, particularly those containing synthetic folic acid. This is due to the recognized importance of nutrition for maternal and fetal health. Folic acid, a synthetic form of the naturally occurring nutrient folate, is essential for metabolism, reproduction, and fetal development during pregnancy. It is also crucial for preventing certain congenital disabilities. These supplements offer potential benefits, such as reducing the risk of specific conditions, including autism spectrum disorder (ASD). However, concerns have arisen regarding their potential impact on children’s brain development, particularly the potential risks of high-dose folic acid supplementation during pregnancy.

2. Unmetabolized Folic Acid

Understanding the difference between natural folate found in food and folic acid in supplements is crucial. Unlike natural folate, primarily absorbed in the intestine, folic acid is processed in the liver. The human enzyme responsible for converting folic acid into its usable form is less efficient than that of other animals, potentially leading to an accumulation of unmetabolized folic acid in the bloodstream. It’s important to note that the issue is not excess folate in general, but specifically excess unmetabolized folic acid. The complexity of this issue is further compounded by individual genetic variations and the enzyme’s lower efficiency in humans, which means some people may experience more significant challenges with excessive unmetabolized folic acid than others.

3. Strategies to Mitigate the Risk of Excessive Unmetabolized Folic Acid

The potential impact of unmetabolized folic acid on fetal brain development, possibly leading to conditions like autism, underscores the need for caution with folic acid supplementation. Initially, a daily intake of around 100 micrograms was considered adequate, but current practices often exceed this amount, accumulating unmetabolized folic acid. Even spacing out the doses does not prevent this buildup. Studies indicate that regardless of dosage frequency, excess unmetabolized folic acid accumulates, particularly after the last dose. This can affect various bodily functions, including enzyme activity, folate absorption, immune function, and brain development.

Excessive folic acid intake has also been linked to other health concerns, such as increased rates of twin births and body fat. To address the issue of unmetabolized folic acid, alternative forms, such as 5-Methyltetrahydrofolate (5-MTHF), are worth considering. Some prenatal vitamins now include 5-MTHF, the active form of folate in the body. This is particularly beneficial for individuals with certain genetic variations who may not produce this active form efficiently. Quatrefoil, a specific form of 5-MTHF, has shown promise in reducing harmful blood markers, especially in those at risk for cardiovascular issues, highlighting the importance of choosing the correct type of folic acid supplement.

4. Neural Development

Maternal health significantly influences fetal brain development, and excessive maternal folic acid intake may have unintended consequences. Animal studies, such as those involving rats, have shown that high maternal folic acid intake can alter brain development, leading to increased seizure susceptibility or behavioral changes like heightened anxiety or hyperactivity in offspring. Other studies have found that high folic acid levels can modify gene expression in the developing brain, potentially impacting its development.

Though these studies utilized folic acid levels far above those recommended for pregnant women, they raise concerns about its possible effects on genes related to autism. A chick embryo study demonstrated that excessive folic acid could inhibit proper nerve growth, which might affect brain development. This suggests that folic acid could compete with specific brain receptors essential for synaptic connections and neuronal growth.

5. Metabolic Abnormalities and Autoantibodies in Autism

Recent research on autism spectrum disorder (ASD) and other neurodevelopmental conditions has identified links to abnormalities in folate metabolism. These issues can manifest in five key areas: immune dysfunction, inflammation, oxidative stress, mitochondrial dysfunction, and environmental toxin exposure. Genetic variations affecting folate metabolism can also influence folate levels in the body. Using specific forms of folate that do not require the standard metabolic pathway, such as folinic acid, has shown promise in improving symptoms, particularly in conditions like cerebral folate deficiency disorder, which shares characteristics with ASD.

6. Is Folic Acid Helpful for Autistic Children?

A recent study involving 48 autistic children with language impairments found that after 12 weeks of folinic acid treatment, 23 children showed improved verbal communication compared to 25 children who received a placebo. While preliminary, these findings suggest potential benefits of folinic acid treatment. Notably, problems with folate transport to the brain’s cerebrospinal fluid are often due to blockage by antibodies, rather than genetic mutations affecting folate receptors. These antibodies, found in many children with autism, can disrupt folate metabolism. Studies in rats have shown that when mothers were exposed to these antibodies during pregnancy and nursing, their offspring exhibited severe behavioral problems. These findings support the use of treatments like folinic acid and highlight the need for careful consideration of folic acid supplementation, particularly for individuals with autism and related conditions.

7. Autism Risk Studies

There is substantial evidence suggesting a link between folic acid (FA) intake and brain development issues. As folic acid supplementation has become more common, an increase in neurodevelopmental disorders like autism has been observed, prompting researchers to investigate whether folic acid intake might influence autism risk. However, studies have produced conflicting results. For example, Surén et al. (2013) and Schmidt et al. (2012) found that folic acid supplementation might reduce autism risk, while DeSoto and Hitlan (2012) and Raghavan et al. (2016) suggested the opposite. These mixed findings highlight the complexity of the relationship between folic acid intake and autism risk and the need for more comprehensive research.

7.1 Surén et al., 2013

In a study by Surén et al. (2013) involving 85,176 children born in Norway between 1999 and 2009, researchers found that folic acid intake around conception was associated with a reduced risk of autism. They analyzed maternal folic acid intake through logistic regression, accounting for parental education, planned pregnancies, and smoking. The study found that the likelihood of autism was about half for those who took folic acid around conception, even after adjusting for other variables.

7.2 Schmidt et al., 2012

An extensive study in Northern California focused on children born after 1999, following the introduction of folic acid fortification in food. The researchers found that prenatal vitamins containing folic acid, taken from three months before conception to one month afterward, were associated with a lower risk of autism, even after considering maternal education and birth year.

7.3 Raghavan et al., 2016, 2017

Two studies by Raghavan et al. examined the relationship between autism risk and folic acid (FA) and vitamin B12 levels at birth. The first study, in 2016, used data from the Boston birth cohort, involving 1,391 births and 107 ASD cases. It was found that high folate levels at birth were associated with a doubled risk of ASD. The 2017 study, involving 1,257 mother-child pairs and 86 ASD cases, found that both low and high levels of multivitamin use were associated with a higher risk of ASD. Very high blood levels of folate and vitamin B12 were linked to a 2.5 times higher risk of ASD.

7.4 DeSoto & Hitlan, 2012

This study used data from the Centers for Disease Control, involving 256 children with ASD and 752 controls. The researchers found a significant association between maternal folic acid intake during pregnancy and ASD, even after adjusting for factors like maternal age and socioeconomic status. Mothers who reported using folic acid were more than twice as likely to have a child diagnosed with ASD.

7.5 Autism Risk Studies

Research on autism risk underscores the importance of adequate folate intake, particularly during early pregnancy. Prenatal vitamins and sufficient folate intake before and during early pregnancy are known to be protective. However, there is no evidence that high doses of folic acid later in pregnancy are beneficial, and some studies suggest they could be harmful. Research in animals and laboratories indicates that excessive folic acid may interfere with brain development. While prenatal vitamins are beneficial early on, excessive folic acid intake, especially in later stages of pregnancy, could pose risks to the developing brain.

8. Discussion

The increasing use of synthetic folic acid supplements before pregnancy reflects a growing awareness of the impact of nutrition on maternal and fetal health. While folic acid has proven effective in preventing congenital disabilities, recent studies suggest a complex relationship with autism spectrum disorder (ASD). Concerns about excess unmetabolized folic acid, enzyme activity, gene expression, and immune function highlight the need for caution. Alternative forms, such as levomefolic acid (5-MTHF) and personalized supplementation, may help mitigate these risks. Animal studies suggest that excessive folic acid might alter gene expression and affect brain development. The presence of autoantibodies in some ASD cases further complicates the picture, emphasizing the need for careful folic acid interventions.

9. Call for More Research

Due to conflicting outcomes, more extensive research is needed to understand the relationship between folic acid and ASD fully. Targeted studies are essential to explore the potential of folic acid in treating children with autism. Additionally, thoroughly examining the best supplementation strategies and potential risks during pregnancy, including long-term effects, is crucial for developing evidence-based recommendations.

10. Conclusion

While the protective effect of folic acid in preventing neural tube defects is well-established, its relationship with ASD is complex and requires careful consideration. Ongoing research is necessary to clarify the nuances of this relationship. Personalized supplementation strategies, alternative forms like 5-MTHF, and a cautious interpretation of conflicting findings should guide recommendations. A balanced and informed approach is essential, recognizing potential benefits while addressing concerns associated with excessive folic acid intake, particularly in unmetabolized forms.

References:

• Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet. 1980 Feb 16;1(8164):339-40. doi: 10.1016/s0140-6736(80)90886-7. PMID: 6101792.
• Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tassone F, Hertz-Picciotto I. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (Childhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr. 2012 Jul;96(1):80-9. Doi: 10.3945/ajcn.110.004416. Epub 2012 May 30. PMID: 22648721; PMCID: PMC3374734.
• Surén P, Roth C, Bresnahan M, Haugen M, Hornig M, Hirtz D, Lie KK, Lipkin WI, Magnus P, Reichborn-Kjennerud T, Schjølberg S, Davey Smith G, Øyen AS, Susser E, Stoltenberg C. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013 Feb 13;309(6):570-7. doi: 10.1001/jama.2012.155925. PMID: 23403681; PMCID: PMC3908544.
• Valera-Gran D, Navarrete-Muñoz EM, Garcia de la Hera M, Fernández-Somoano A, Tardón A, Ibarluzea J, Balluerka N, Murcia M, González-Safont L, Romaguera D, Julvez J, Vioque J; INMA Project. Effect of maternal high dosages of folic acid supplements on neurocognitive development in children at 4-5 y of age: the prospective birth cohort Infancia y Medio Ambiente (INMA) study. Am J Clin Nutr. 2017 Sep;106(3):878-887. doi: 10.3945/ajcn.117.152769. Epub 2017 Jul 19. PMID: 28724645.
• darrell wiens and M. Catherine DeSoto. Is Folic acid Intake a Risk Factor for Autism? – a Review. Brain Sci. 2017,7,149; doi:10.3390/brainsci7110149
• Raghavan R, Riley AW, Volk H, Caruso D, Hironaka L, Sices L, Hong X, Wang G, Ji Y, Brucato M, Wahl A, Stivers T, Pearson C, Zuckerman B, Stuart EA, Landa R, Fallin MD, Wang X. Maternal Multivitamin Intake, Plasma Folate and Vitamin B₁₂Levels and Autism Spectrum Disorder Risk in Offspring. Paediatr Perinat Epidemiol. 2018 Jan;32(1):100-111. Doi: 10.1111/ppe.12414. Epub 2017 Oct 6. PMID: 28984369; PMCID: PMC5796848.
• Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S, Jill James S, Sequeira JM, Quadros EV. Folinic acid improves verbal communication in children with autism and language impairment: a randomized, double-masked placebo-controlled trial. Mol Psychiatry. 2018 Feb;23(2):247-256. doi: 10.1038/mp.2016.168. Epub 2016 Oct 18. PMID: 27752075; PMCID: PMC5794882.
• Desoto, Mary & Hitlan, Robert. (2011). Synthetic folic acid supplementation during pregnancy may increase the risk of developing autism. J Pediatr Biochem. 2. 10.3233/JPB-120066.
• Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989 Nov 24;262(20):2847-52. doi: 10.1001/jama.262.20.2847. PMID: 2478730.
• Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988 Dec 2;260(21):3141-5. PMID: 3184392.
• Ramaekers VT, Häusler M, Opladen T, Heimann G, Blau N. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Neuropediatrics. 2002 Dec;33(6):301-8. doi: 10.1055/s-2002-37082. PMID: 12571785.
• Warzyszynska, Joanna & Kim, Young-In. (2014). Folate in Human Health and Disease. 10.1002/9780470015902.a0002268.pub2.
• Rosenquist TH. Folate, homocysteine and the cardiac neural crest. Dev Dyn. 2013 Mar;242(3):201-18. doi: 10.1002/dvdy.23922. Epub 2013 Feb 8. PMID: 23335187.
• van Gool JD, Hirche H, Lax H, De Schaepdrijver L. Folic acid and primary prevention of neural tube defects: A review. Reprod Toxicol. 2018 Sep;80:73-84. doi: 10.1016/j.reprotox.2018.05.004. Epub 2018 May 16. PMID: 29777755.
• Grapp M, Just IA, Linnankivi T, Wolf P, Lücke T, Häusler M, Gärtner J, Steinfeld R. Molecular characterization of folate receptor one mutation delineates cerebral folate transport deficiency. Brain. 2012 Jul;135(Pt 7):2022-31. doi: 10.1093/brain/aws122. Epub 2012 May 13. PMID: 22586289.
• Ramaekers VT, Sequeira JM, Blau N, Quadros EV. A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome. Dev Med Child Neurol. 2008 May;50(5):346-52. doi: 10.1111/j.1469-8749.2008.02053.x. Epub 2008 Mar 19. PMID: 18355335; PMCID: PMC2715943.
• Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry. 2013 Mar;18(3):369-81. doi: 10.1038/mp.2011.175. Epub 2012 Jan 10. PMID: 22230883; PMCID: PMC3578948.
• Ramaekers VT, Quadros EV, Sequeira JM. Role of folate receptor autoantibodies in infantile autism. Mol Psychiatry. 2013 Mar;18(3):270-1. doi: 10.1038/mp.2012.22. Epub 2012 Apr 10. PMID: 22488256.
• Sequeira JM, Desai A, Berrocal-Zaragoza MI, Murphy MM, Fernandez-Ballart JD, et al. (2016) Exposure to Folate Receptor Alpha Antibodies during Gestation and Weaning Leads to Severe Behavioral Deficits in Rats: A Pilot Study. PLOS ONE 11(3): e0152249. https://doi.org/10.1371/journal.pone.0152249
• Hoyo C, Murtha AP, Schildkraut JM, Forman MR, Calingaert B, Demark-Wahnefried W, Kurtzberg J, Jirtle RL, Murphy SK. Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST). BMC Public Health. 2011 Jan 21;11(1):46. Doi: 10.1186/1471-2458-11-46. PMID: 21255390; PMCID: PMC3038155.